Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Paptizer 360

K-Number: K252471 · 2026-04-29

Decision Date2026-04-29
Product CodeQXQ
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

Paptizer 360 is the device name listed in this FDA 510(k) record. The listed applicant is LiViliti Health Products Corporation. It received FDA 510(k) clearance on 2026-04-29 under 510(k) number K252471. The device is classified under product code QXQ. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Paptizer 360?

Paptizer 360 is a medical device that received FDA 510(k) clearance on 2026-04-29. The listed applicant is LiViliti Health Products Corporation. The 510(k) number is K252471.

When did Paptizer 360 receive FDA 510(k) clearance?

Paptizer 360 received FDA 510(k) clearance on 2026-04-29, under 510(k) number K252471.

Who is the listed applicant for Paptizer 360?

The FDA 510(k) record lists LiViliti Health Products Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Paptizer 360?

The FDA product code for Paptizer 360 is QXQ.

Related Devices (Code: QXQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.